Professor of Clinical Neuroscience
Psychiatry
Dr. Floyd R. Sallee, MD
|
|
Give Review
Floyd R. Sallee is an expert in the field of Psychiatry. He attended University of Pittsburgh School of Medicine. He over the years received 3 awards: "NARSAD", "Developmental Scholars Award, MUSC" and "Sandoz Award in Psychiatry". Floyd Sallee is also a published doctor. He has 57 paper published. The most recent paper is: Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers.
Publications
- Pozanicline for the treatment of attention-deficit/hyperactivity disorder.
- Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers.
- On the expansion of ribosomal proteins and RNAs in eukaryotes.
- Reduced Short Interval Cortical Inhibition Correlates With Atomoxetine Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
- Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
- Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse.
- Pediatric drug research and mental illness.
- Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.
- Dimers of g-protein coupled receptors as versatile storage and response units.
- Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.
- Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
- Divalproex-ER pharmacokinetics in older children and adolescents.
- Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
- A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome.
- The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: p...
- Adderall XR: long acting stimulant for single daily dosing.
- Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.
- Neuropeptide Y as a partial agonist of the Y1 receptor.
- Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
- A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
- Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.
- Dopamine transporter genotype influences the physiological response to medication in ADHD.
- Social anxiety disorder in childhood and adolescence: descriptive psychopathology.
- Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor.
- Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.
- Relevance of neuropeptide Y (NPY) in psychiatry.
- SET-C versus fluoxetine in the treatment of childhood social phobia.
- Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
- Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.
- A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity d...
- Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
- Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor.
- Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.
- Acid-sensing by the T cell death-associated gene 8 (TDAG8) receptor cloned from rat brain.
- Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
- Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder.
- An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
- Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues?
- Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.
- The illusion of mental health: in the mind of which beholder?
- Two intracellular helices of G-protein coupling receptors could generally support oligomerization and coupling with transducers.
- Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers.
- Enhanced fear recall and emotional arousal in rats recovering from chronic variable stress.
- Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a ...
- Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).
- The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
- Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress.
- The use of lisdexamfetamine dimesylate for the treatment of ADHD.
- The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHD: Does Composition Matter?
- Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
- Single-dose pharmacokinetics of NWP06, an extended-release methylphenidate suspension, in children and adolescents with ADHD.
- Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.
- Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.
- Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.
- Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
- Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.
Schools
Southern Illinois University At Edwardsville
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- NARSAD
- Developmental Scholars Award, MUSC
- Sandoz Award in Psychiatry
Education
-
University of Pittsburgh School of Medicine -
Children's Hospital of Philadelphia -
University of Illinois
Hospital
-
University of Cincinnati Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. John A. Pybass, MD |
|
|
Dr. Stephen J. Brasseux, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regana C. Sisson, MD |
|
|
Dr. Catherine E. Louis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lydia W. Haren, MD |
|
|
Dr. Elmina L. Summerall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milton J. Foust Jr., MD
This Doctor is OpenDoctor Recommended.
|